What is the number needed to screen (NNS) and how is it calculated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Number Needed to Screen (NNS): Definition and Calculation

The Number Needed to Screen (NNS) is calculated as the inverse of the absolute risk reduction (ARR), expressed mathematically as NNS = 1/ARR, where ARR represents the difference in event rates (typically mortality) between screened and unscreened populations. 1

Core Calculation Method

Basic Formula:

  • NNS = 1 / [(Control event rate) − (Screened event rate)] 1
  • The ARR is obtained by subtracting the event rate in the screened group from the event rate in the control (unscreened) group 1
  • When expressed in mortality terms: NNS = 1 / [(Deaths per person in control) − (Deaths per person in screened)] 1

Alternative Calculation Method:

  • NNS can be estimated by multiplying the Number Needed to Treat (NNT) by the number of people who must be screened to find one patient with the disease 2, 3
  • This approach is useful when direct mortality data from screening trials are unavailable 3

Critical Adjustment for Follow-Up Duration

Time-adjusted NNS must be based on mortality rates per person-year rather than per person over the entire study period to avoid systematic overestimation. 1

Adjustment Formula:

  • For a standardized comparison period of X years: Adjusted NNS = (Crude NNS) / X 1
  • Example: A crude NNS of 2,399 over 13 years yields a 10-year adjusted NNS of approximately 1,845 (2,399 × 10/13) 1
  • Shorter follow-up periods inherently produce higher NNS values, potentially making effective interventions appear less beneficial 4, 1

Common Pitfall:

  • The USPSTF methodology for breast cancer screening omitted this adjustment, producing biased comparisons between age groups (women 40-49 years: reported NNS = 1,904 vs. adjusted ≈ 1,599 for 15 years; women 50-59 years: reported = 1,339 vs. adjusted ≈ 1,708 for 15 years) 4, 1
  • NNS values should never be compared across studies unless the follow-up duration is standardized 1

Deriving NNS from Relative Risk

When only pooled relative risk (RR) data are available:

  • Calculate ARR as: ARR = Baseline rate × (1 − RR) 1
  • Then apply: NNS = 1 / ARR 1
  • Example: For breast cancer screening with RR = 0.80 (20% risk reduction) and baseline mortality of 0.005, ARR = 0.001 and NNS = 1,000 1

Accounting for Participation and Selection Effects

The Number Needed to Be Screened (NNBS) adjusts for real-world participation rates and selection bias, providing a more accurate estimate than crude NNS. 5

  • NNBS is derived from NNT adjusted for participation in screening and selection effects associated with participation 5
  • For breast cancer screening, NNBS was 23% lower than crude NNS (NNBS = 601 vs. NNS = 781) 5
  • For colorectal cancer screening, NNBS was 45% lower than crude NNS (NNBS = 688 vs. NNS = 1,250) 5
  • This adjustment is especially important when comparing screening programs with disparate participation rates 5

Population-Specific Considerations

Baseline risk strongly influences NNS; therefore, age-stratified or risk-stratified calculations are essential and should never be pooled across heterogeneous groups. 1

  • Higher-risk populations consistently exhibit lower NNS, indicating more efficient screening 1
  • Example from tuberculosis screening in migrants: median NNS = 231 (IQR 1,022) to detect one case of active TB 4
  • Example from prostate cancer screening (ERSPC): NNS decreased from 1,410 at 9 years to an estimated 503 at 12 years with continued follow-up 4, 6

Time-Dependent Nature of NNS

NNS is inherently time-specific and decreases with longer follow-up as cumulative mortality differences grow between screened and control groups. 6

  • In the ERSPC prostate cancer trial, NNS decreased from 1,254 at year 9 to 837 at year 10 and 503 at year 12 6
  • Reporting NNS at a single time point may lead to misinterpretation of screening benefits 6
  • For chronic conditions requiring long-term follow-up, annualized NNS should be calculated to account for varying study durations 1

Confidence Intervals

  • Confidence intervals for NNS are obtained by inverting and exchanging the confidence limits for the ARR 7
  • The Wilson score method provides more accurate confidence intervals than the standard asymptotic method, which often yields intervals that are too narrow 7
  • Always verify that the underlying ARR is statistically significant before interpreting NNS 1

Practical Examples from Current Screening Programs

Based on published data from the Netherlands:

  • Cervical cancer screening: NNS ≈ 2,560 per year to prevent one death 2
  • Breast cancer screening: NNS ≈ 1,000 per year to prevent one death 2
  • Hypertension detection (ages 55-75): NNS ≈ 2,340 per year to prevent one death 2
  • Colorectal cancer screening (hemoccult): NNS = 1,374 for 5 years to prevent one colon cancer death 3

References

Guideline

Number Needed to Screen (NNS): Definition, Calculation, and Adjustments

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

['Number needed to screen': a tool for assessment of prevention programs].

Nederlands tijdschrift voor geneeskunde, 2000

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Screening and the number needed to treat.

Journal of medical screening, 2001

Research

What is the true number needed to screen and treat to save a life with prostate-specific antigen testing?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011

Research

Improving the calculation of confidence intervals for the number needed to treat.

Studies in health technology and informatics, 2000

Related Questions

How do I calculate the number needed to screen (NNS) for a screening program?
What is the number needed to vaccinate (NNV) to prevent one hospitalization in individuals over 50 years old?
What conditions should a screening clinic prioritize to reduce morbidity and mortality?
What health screenings are recommended for adults?
What is the number needed to treat (NNT) to prevent one death from prostate cancer with a Prostate-Specific Antigen (PSA) test?
In an adult who develops foot stiffness and pain after prolonged inactivity (e.g., a long car ride), what are the likely causes and concerning conditions to consider?
What is a daily protocol for weaning an adult intensive care unit (ICU) patient from mechanical ventilation, including readiness criteria (improving underlying problem, adequate partial pressure of arterial oxygen (PaO2) >55 mmHg on fraction of inspired oxygen (FiO2) ≤0.40, PaO2/FiO2 ≥200, stable hemodynamics without vasopressors, light sedation, positive end‑expiratory pressure (PEEP) ≤5 cm H2O, pressure support ≤8 cm H2O, and rapid shallow breathing index (RSBI) ≤105 breaths/min/L), spontaneous breathing trial (SBT) settings and stop criteria, post‑extubation oxygen targets and prophylactic non‑invasive ventilation (NIV) or high‑flow nasal cannula (HFNC) for high‑risk patients, definition of extubation success, and management of difficult or prolonged weaning?
Is it safe to continue propranolol for anxiety and hypertension while using methamphetamine?
In an adult patient with an acute rise in serum creatinine, which test best differentiates pre‑renal acute kidney injury from intrinsic acute kidney injury: urine specific gravity, serum creatinine level, fractional excretion of sodium (FeNa), or BUN/creatinine ratio?
Can foot stiffness and pain after a period of inactivity be a symptom of rheumatoid arthritis?
How is the number needed to screen calculated?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.